白云山(00874)发布公告,近日,该公司分公司广州白云山医药集团股份有限公司白云...白云山(00874)发布公告,近日,该公司分公司广州白云山医药集团股份有限公司白云山制药总厂(以下简称“白云山制药总厂”)收到国家药品监督管理局核准签发关于他达拉非片(2.5mg、5mg)的《药品注册证书》。公告称,本次获得他达拉非片(2.5mg、5mg)的《药品注册证书》,丰富了白云山制药总厂男性用药产品的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.